141 related articles for article (PubMed ID: 24905836)
1. Nonparametric Prediction of Event Times for Analysis of Failure-Time Data.
Lustgarten S; Doros G
J Biopharm Stat; 2015; 25(4):695-713. PubMed ID: 24905836
[TBL] [Abstract][Full Text] [Related]
2. Joint monitoring and prediction of accrual and event times in clinical trials.
Zhang X; Long Q
Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
[TBL] [Abstract][Full Text] [Related]
3. Adaptive parametric prediction of event times in clinical trials.
Lan Y; Heitjan DF
Clin Trials; 2018 Apr; 15(2):159-168. PubMed ID: 29376735
[TBL] [Abstract][Full Text] [Related]
4. Predicting analysis time in event-driven clinical trials with event-reporting lag.
Wang J; Ke C; Jiang Q; Zhang C; Snapinn S
Stat Med; 2012 Apr; 31(9):801-11. PubMed ID: 22344853
[TBL] [Abstract][Full Text] [Related]
5. Predicting event times in clinical trials when treatment arm is masked.
Donovan JM; Elliott MR; Heitjan DF
J Biopharm Stat; 2006 May; 16(3):343-56. PubMed ID: 16724489
[TBL] [Abstract][Full Text] [Related]
6. Bayesian monitoring of clinical trials with failure-time endpoints.
Rosner GL
Biometrics; 2005 Mar; 61(1):239-45. PubMed ID: 15737099
[TBL] [Abstract][Full Text] [Related]
7. Nonparametric prediction of event times in randomized clinical trials.
Ying GS; Heitjan DF; Chen TT
Clin Trials; 2004; 1(4):352-61. PubMed ID: 16279273
[TBL] [Abstract][Full Text] [Related]
8. Bayesian joint modeling of longitudinal measurements and time-to-event data using robust distributions.
Baghfalaki T; Ganjali M; Hashemi R
J Biopharm Stat; 2014; 24(4):834-55. PubMed ID: 24697192
[TBL] [Abstract][Full Text] [Related]
9. Predicting event times in clinical trials when randomization is masked and blocked.
Donovan JM; Elliott MR; Heitjan DF
Clin Trials; 2007; 4(5):481-90. PubMed ID: 17942464
[TBL] [Abstract][Full Text] [Related]
10. A hybrid approach to predicting events in clinical trials with time-to-event outcomes.
Fang L; Su Z
Contemp Clin Trials; 2011 Sep; 32(5):755-9. PubMed ID: 21645644
[TBL] [Abstract][Full Text] [Related]
11. Sample size reestimation by Bayesian prediction.
Wang MD
Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
[TBL] [Abstract][Full Text] [Related]
12. Bayesian bootstrap estimation of ROC curve.
Gu J; Ghosal S; Roy A
Stat Med; 2008 Nov; 27(26):5407-20. PubMed ID: 18613217
[TBL] [Abstract][Full Text] [Related]
13. Why preferring parametric forecasting to nonparametric methods?
Jabot F
J Theor Biol; 2015 May; 372():205-10. PubMed ID: 25769942
[TBL] [Abstract][Full Text] [Related]
14. Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate information.
Wang J; Ke C; Yu Z; Fu L; Dornseif B
Pharm Stat; 2016 May; 15(3):198-207. PubMed ID: 26689725
[TBL] [Abstract][Full Text] [Related]
15. A semi-parametric Bayesian approach to average bioequivalence.
Ghosh P; Rosner GL
Stat Med; 2007 Mar; 26(6):1224-36. PubMed ID: 16832840
[TBL] [Abstract][Full Text] [Related]
16. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
17. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
Zhang X; Long Q
Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
[TBL] [Abstract][Full Text] [Related]
18. Continuous event monitoring via a Bayesian predictive approach.
Di J; Wang D; Brashear HR; Dragalin V; Krams M
Pharm Stat; 2016; 15(2):109-22. PubMed ID: 26643012
[TBL] [Abstract][Full Text] [Related]
19. Nonparametric comparison of two survival functions with dependent censoring via nonparametric multiple imputation.
Hsu CH; Taylor JM
Stat Med; 2009 Feb; 28(3):462-75. PubMed ID: 18991250
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian estimate of the concordance correlation coefficient with skewed data.
Feng D; Baumgartner R; Svetnik V
Pharm Stat; 2015; 14(4):350-8. PubMed ID: 26033433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
